Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian A Gordon

Showing results (201-210 of 262) with videos related to

Pageof 27
Sort By:
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Alzheimer's Imaging ConsortiumEmma Ruppert, Marina Scop Medeiros, Marie R Vermeiren, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 23, 2023
Investigation of sex differences in mutation carriers of the Dominantly Inherited Alzheimer NetworkOlivia Wagemann, Yan Li, Jason Hassenstab, et al.
Neurology|August 7, 2015
Cerebral amyloidosis associated with cognitive decline in autosomal dominant Alzheimer diseaseFen Wang, Brian A Gordon, Davis C Ryman, et al.
Brain : a Journal of Neurology|January 10, 2023
Brain network decoupling with increased serum neurofilament and reduced cognitive function in Alzheimer's diseaseMuriah D Wheelock, Jeremy F Strain, Patricia Mansfield, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
BiomarkersEmma Ruppert, Marina Scop Medeiros, Marie R Vermeiren, et al.
The Lancet. Neurology|December 14, 2022
Comparison of amyloid burden in individuals with Down syndrome versus autosomal dominant Alzheimer's disease: a cross-sectional studyAnna H Boerwinkle, Brian A Gordon, Julie Wisch, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|November 9, 2022
Evaluation of dose-dependent treatment effects after mid-trial dose escalation in biomarker, clinical, and cognitive outcomes for gantenerumab or solanezumab in dominantly inherited Alzheimer's diseaseGuoqiao Wang, Yan Li, Chengjie Xiong, et al.
Medrxiv : the Preprint Server for Health Sciences|March 27, 2026
OpenScientist: evaluating an open agentic AI co-scientist to accelerate biomedical discoveryKaleigh F Roberts, Zachary B Abrams, Luca Cappelletti, et al.
Neurobiology of Disease|March 31, 2022
CSF Tau phosphorylation at Thr205 is associated with loss of white matter integrity in autosomal dominant Alzheimer diseaseJeremy F Strain, Nicolas Barthelemy, Kanta Horie, et al.
The Lancet. Neurology|July 29, 2024
γ-Secretase activity, clinical features, and biomarkers of autosomal dominant Alzheimer's disease: cross-sectional and longitudinal analysis of the Dominantly Inherited Alzheimer Network observational study (DIAN-OBS)Stephanie A Schultz, Lei Liu, Aaron P Schultz, et al.
Pageof 27

Showing results (201-210 of 262) with videos related to

Sort By:
Pageof 27
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Alzheimer's Imaging ConsortiumEmma Ruppert, Marina Scop Medeiros, Marie R Vermeiren, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 23, 2023
Investigation of sex differences in mutation carriers of the Dominantly Inherited Alzheimer NetworkOlivia Wagemann, Yan Li, Jason Hassenstab, et al.
Neurology|August 7, 2015
Cerebral amyloidosis associated with cognitive decline in autosomal dominant Alzheimer diseaseFen Wang, Brian A Gordon, Davis C Ryman, et al.
Brain : a Journal of Neurology|January 10, 2023
Brain network decoupling with increased serum neurofilament and reduced cognitive function in Alzheimer's diseaseMuriah D Wheelock, Jeremy F Strain, Patricia Mansfield, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
BiomarkersEmma Ruppert, Marina Scop Medeiros, Marie R Vermeiren, et al.
The Lancet. Neurology|December 14, 2022
Comparison of amyloid burden in individuals with Down syndrome versus autosomal dominant Alzheimer's disease: a cross-sectional studyAnna H Boerwinkle, Brian A Gordon, Julie Wisch, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|November 9, 2022
Evaluation of dose-dependent treatment effects after mid-trial dose escalation in biomarker, clinical, and cognitive outcomes for gantenerumab or solanezumab in dominantly inherited Alzheimer's diseaseGuoqiao Wang, Yan Li, Chengjie Xiong, et al.
Medrxiv : the Preprint Server for Health Sciences|March 27, 2026
OpenScientist: evaluating an open agentic AI co-scientist to accelerate biomedical discoveryKaleigh F Roberts, Zachary B Abrams, Luca Cappelletti, et al.
Neurobiology of Disease|March 31, 2022
CSF Tau phosphorylation at Thr205 is associated with loss of white matter integrity in autosomal dominant Alzheimer diseaseJeremy F Strain, Nicolas Barthelemy, Kanta Horie, et al.
The Lancet. Neurology|July 29, 2024
γ-Secretase activity, clinical features, and biomarkers of autosomal dominant Alzheimer's disease: cross-sectional and longitudinal analysis of the Dominantly Inherited Alzheimer Network observational study (DIAN-OBS)Stephanie A Schultz, Lei Liu, Aaron P Schultz, et al.
Pageof 27